Preclinical Evaluation of an Al18F-Radiolabeled Bicyclic Peptide Targeting Nectin-4

Precisely assessing nectin-4 expression in tumors is important in identifying patients who may benefit from nectin-4-targeted therapies. In our previous work, we developed a bicyclic peptide-based nectin-4-targeting radiotracer